Insider Buying: Vical VP Buys 90,000 Shares of Stock (VICL)
Vical (NASDAQ:VICL) VP Igor Bilinsky purchased 90,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were purchased at an average cost of $1.42 per share, for a total transaction of $127,800.00. Following the completion of the purchase, the vice president now directly owns 143,968 shares of the company’s stock, valued at approximately $204,435. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Vical (NASDAQ:VICL) traded up 7.09% on Tuesday, hitting $1.435. 2,336,806 shares of the company’s stock traded hands. Vical has a one year low of $1.01 and a one year high of $4.51. The stock has a 50-day moving average of $1.16 and a 200-day moving average of $1.7. The company’s market cap is $124.5 million.
Vical (NASDAQ:VICL) last announced its earnings results on Thursday, October 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.01. The company had revenue of $1.50 million for the quarter, compared to the consensus estimate of $1.82 million. During the same quarter in the previous year, the company posted ($0.09) earnings per share. The company’s revenue for the quarter was down 31.8% on a year-over-year basis. Analysts expect that Vical will post $-0.42 EPS for the current fiscal year.
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (NASDAQ:VICL) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.